StockNews.AI
HCAT
StockNews.AI
218 days

Health Catalyst Recognized as a Leader in Frost & Sullivan's 2024 US Population Health Management Report

1. Health Catalyst recognized as a leader in PHM market by Frost Radar™. 2. Company's Population Health suite enhances care delivery with advanced analytics. 3. Recent acquisitions improve capabilities in oncology care management and patient communication. 4. Health Catalyst focuses on growth in underserved segments like ambulatory practices. 5. Recognition underscores commitment to value-based care and innovative healthcare solutions.

6m saved
Insight
Article

FAQ

Why Bullish?

Recognition as a leader boosts HCAT's market credibility and attractiveness, similar to past accolades that led to stock price increases.

How important is it?

The recognition directly impacts HCAT's reputation, driving potential investor interest and market confidence.

Why Long Term?

Continued innovation and market leadership signal sustainable growth potential, much like previous trends with durable tech firms.

Related Companies

COVOMIABMD
, /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced its recognition in the Frost Radar™: US Population Health Management, 2024 report. In the report, Health Catalyst is recognized as a leader in innovation, cementing its position as a top provider in the competitive population health management (PHM) market.Frost & Sullivan analysts assessed more than 50 companies in the United States PHM market based on their innovation and growth strategies, spotlighting those driving transformative healthcare advancements. Health Catalyst received recognition as a leader in the industry for its Population Health suite, which provides clients with financial and quality benchmarking tools, administrative support, and advanced analytics to enhance care delivery and outcomes.The report lauded Health Catalyst's optimization efforts: "Health Catalyst revolutionized how third-party PHM IT initiatives are optimized. It offers custom configuration, a pre-built rules engine, and superior data management capabilities to ensure that every PHM initiative is successful.""Being recognized in the 2024 Frost Radar™: US Population Health Management report reflects Health Catalyst's ongoing commitment to addressing healthcare's most pressing challenges through innovation and client-centric solutions," said Dan Burton, CEO of Health Catalyst. "We are thrilled to contribute to the transition toward value-based care. In line with our multi-decade mission, we are dedicated to equipping healthcare organizations with the tools to facilitate data-informed healthcare improvement, operational efficiency, and ultimately, improved patient outcomes." The report further highlights Health Catalyst's proactive approach to innovation, addressing pressing industry challenges, and consistently strengthening its portfolio with acquisitions like Carevive and Lumeon. The report noted that these acquisitions enhanced Health Catalyst's capabilities in oncology care management and patient communication, reinforcing Health Catalyst's dedication to meet evolving market demands."Health Catalyst, with a balanced focus on growth and innovation, holds a solid position to ensure the success of population health management initiatives through its comprehensive and flexible PHM portfolio that seamlessly accommodates the needs of clients of all sizes with custom configuration, a pre-built rules engine, and superior data management capabilities," said Sagar Mukhekar, Industry Analyst at Frost & Sullivan.Additionally, Frost & Sullivan analysts commended Health Catalyst's strong commitment to innovation, emphasizing its use of client feedback to keep its solutions closely aligned with industry trends. The company's strategic expansion into underserved segments, including ambulatory practices and smaller healthcare organizations, further solidifies its leadership in the PHM market.About Health CatalystHealth Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.Media Contact:Amanda FlandersSenior Vice President of Marketing and Communications[email protected]808.743.1781

Related News